Meeting of the Advisory Committee on Minority Health, 50652-50653 [2017-23816]

Download as PDF 50652 Federal Register / Vol. 82, No. 210 / Wednesday, November 1, 2017 / Notices Background GENERAL SERVICES ADMINISTRATION [Notice–PBS–2017–02; Docket 2017–0002; Sequence 21] Notice of intent To Prepare a Supplemental Environmental Impact Statement for the San Ysidro Land Port of Entry (LPOE) Modernization and Expansion Project Public Building Service (PBS), General Services Administration (GSA). ACTION: Notice of intent; Announcement of meeting. AGENCY: Pursuant to the requirements of the National Environmental Policy Act of 1969 (NEPA), the Council on Environmental Quality Regulations, and the GSA Public Buildings Service NEPA Desk Guide, GSA is issuing this notice to advise the public that a Supplemental Environmental Impact Statement (SEIS) will be prepared for the San Ysidro LPOE Modernization and Expansion Project (Project). DATES: Meeting Date: A public scoping meeting will be held on Wednesday, November 8th, 2017 from 4:00 p.m., Pacific Time (PT), to 6:00 p.m., PT. The meeting will be an informal open house, where visitors may come, receive information, and provide written comments. Agencies and the public are encouraged to provide written comments regarding the scope of the SEIS. Written comments must be received by November 30, 2017. ADDRESSES: The public scoping meeting will be held at The Front, 147 West San Ysidro Boulevard, San Ysidro, CA 92173. Written comments must be sent to the General Services Administration, Attention: Osmahn Kadri, Regional Environmental Quality Advisor/NEPA Project Manager, 50 United Nations Plaza, Room 3345 Mailbox 9, San Francisco, CA 94102, or via email to osmahn.kadri@gsa.gov. FOR FURTHER INFORMATION CONTACT: Osmahn A. Kadri, Regional Environmental Quality Advisor/NEPA Project Manager, GSA, Pacific Rim Region, at 415–522–3617. Please also call this number if special assistance is needed to attend and participate in the public scoping meeting. SUPPLEMENTARY INFORMATION: GSA intends to prepare a SEIS to analyze the potential impacts resulting from proposed modifications and minor design changes to the San Ysidro LPOE Modernization and Expansion Project. The San Ysidro LPOE is located at the terminus of Interstate 5 at the United States-Mexico border in the San Ysidro community of San Diego, California. sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:16 Oct 31, 2017 Jkt 244001 A Final Environmental Impact Statement (EIS) and Record of Decision (ROD) were published in September 2009. Both addressed the reconfiguration and expansion of the San Ysidro LPOE in three independent construction phases to improve overall capacity and operational efficiency. In May 2014, GSA published a Final SEIS and ROD that evaluated changed circumstances and proposed modifications to the Project, including (1) the incorporation of northbound pedestrians inspections at the proposed southbound-only pedestrian crossing facility, on the west side of the LPOE, and modification of the phasing/timing of the construction of the pedestrian crossing facility; (2) changes to the development footprint on the west side of the LPOE and design refinements to the Virginia Avenue Transit Center; (3) a change in the number of vehicle lanes and the installation of southbound inspection booths and overhead canopies on the proposed southbound roadway; and (4) minor changes in the design and/or timing of implementation of several Project elements. GSA prepared a Revision to the Final SEIS in August 2015 that addressed minor changes to the alignment of the southbound roadway and employee access road, as well as specific information that was not known or available at the time the Final EIS or Final SEIS were prepared (regarding the details of the on-site wastewater treatment facility). Phase 1 is complete and included the construction of a pedestrian bridge, additional northbound vehicle lanes and inspection facilities, a new southbound pedestrian crossing facility on the east side of the LPOE, a new bidirectional pedestrian crossing facility on the west side of the LPOE, and the Virginia Avenue Transit Center. Phase 2 is fully funded and involves the construction of new buildings. Phase 3 is fully funded and includes construction of a southbound roadway and associated inspection equipment. Phases 2 and 3 are anticipated to be completed in 2019. The SEIS will address changes to the Project, which include acquisition of one parcel of land on the east side of the LPOE and incorporation of this additional land area into the LPOE. Alternatives Under Consideration Two action alternatives are under consideration in addition to the NoAction Alternative. Alternative 1 would include demolition of the existing building on the acquisition site and PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 expansion of the LPOE pedestrian plaza. Alternative 2 would involve renovating the existing on-site building. The No Action Alternative assumes that the site would not be acquired by GSA and the additional land area would not be incorporated into the LPOE. Scoping Process Scoping will be accomplished through a public scoping meeting, direct mail correspondence to appropriate federal, state, and local agencies, and to private organizations and citizens who have previously expressed, or are known to have, an interest in the Project. Dated: October 23, 2017. Matthew Jear, Director, Portfolio Management Division, Pacific Rim Region, Public Buildings Service. [FR Doc. 2017–23754 Filed 10–31–17; 8:45 am] BILLING CODE 6820–Y1–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Minority Health Office of Minority Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the Advisory Committee on Minority Health (ACMH) will hold a meeting conducted as a telephone conference call. This call will be open to the public. Preregistration is required for both public participation and comment. Any individual who wishes to participate in the call should email OMH-ACMH@hhs.gov by December 4, 2017. Instructions regarding participating in the call and how to provide verbal public comments will be given at the time of preregistration. Information about the meeting is available from the designated contact and will be posted on the Web site for the Office of Minority Health (OMH), www.minorityhealth.hhs.gov. Information about ACMH activities can be found on the OMH Web site under the heading About OMH. DATES: The conference call will be held on December 5, 2017, 1:00 p.m.–3:00 p.m. ET. ADDRESSES: Instructions regarding participating in the call will be given at the time of preregistration. SUMMARY: E:\FR\FM\01NON1.SGM 01NON1 Federal Register / Vol. 82, No. 210 / Wednesday, November 1, 2017 / Notices Dr. Minh Wendt, Designated Federal Officer, Advisory Committee on Minority Health, Office of Minority Health, Department of Health and Human Services, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240–453–8222; fax: 240–453–8223; email OMH-ACMH@ hhs.gov. FOR FURTHER INFORMATION CONTACT: In accordance with Public Law 105–392, the ACMH was established to provide advice to the Deputy Assistant Secretary for Minority Health on improving the health of each racial and ethnic minority group and on the development of goals and specific program activities of the OMH. The topics to be discussed during the teleconference include finalizing recommendations regarding improving the access and quality of data related to the opioid usage and health disparities. The recommendations will be given to the Deputy Assistant Secretary for Minority Health. This call will be limited to 125 participants. The OMH will make every effort to accommodate persons with special needs. Individuals who have special needs for which special accommodations may be required should contact Professional and Scientific Associates at (703) 234–1700 and reference this meeting. Requests for special accommodations should be made at least ten (10) business days prior to the meeting. Members of the public will have an opportunity to provide comments at the meeting. Public comments will be limited to two minutes per speaker during the time allotted. Individuals who would like to submit written statements should email, mail, or fax their comments to the designated contact at least seven (7) business days prior to the meeting. Any members of the public who wish to have electronic or printed material distributed to ACMH members should email OMH-ACMH@hhs.gov or mail their materials to the Designated Federal Officer, ACMH, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852, prior to close of business on November 28, 2017. sradovich on DSK3GMQ082PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: October 27, 2017. Minh Wendt, Designated Federal Officer, Advisory Committee on Minority Health. [FR Doc. 2017–23816 Filed 10–31–17; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meeting Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Time-Sensitive Review of potential exposures associated with Hurricane Harvey. Date: November 20, 2017. Time: 11:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: NIEHS/National Institutes of Health, Keystone Building, 530 Davis Drive, Room 3003, Research Triangle Park, NC 27709, (Telephone Conference Call). Contact Person: Laura A, Thomas, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, 919–541–2824, laura.thomas@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: October 27, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–23815 Filed 10–31–17; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4150–29–P VerDate Sep<11>2014 18:16 Oct 31, 2017 Jkt 244001 50653 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Virology. Date: November 3, 2017. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: John C Pugh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435– 2398, pughjohn@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in the Vision Biology. Date: November 29, 2017. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Janet M. Larkin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1102, MSC 7840, Bethesda, MD 20892, 301–806– 2765, larkinja@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Tobacco Regulatory Science (R01, R21, R03). Date: December 5, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Mark Caprara, Ph.D., Scientific Review Officer, Center for E:\FR\FM\01NON1.SGM 01NON1

Agencies

[Federal Register Volume 82, Number 210 (Wednesday, November 1, 2017)]
[Notices]
[Pages 50652-50653]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23816]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Advisory Committee on Minority Health

AGENCY: Office of Minority Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Advisory Committee on Minority Health (ACMH) will hold a 
meeting conducted as a telephone conference call. This call will be 
open to the public. Preregistration is required for both public 
participation and comment. Any individual who wishes to participate in 
the call should email [email protected] by December 4, 2017. 
Instructions regarding participating in the call and how to provide 
verbal public comments will be given at the time of preregistration.
    Information about the meeting is available from the designated 
contact and will be posted on the Web site for the Office of Minority 
Health (OMH), www.minorityhealth.hhs.gov. Information about ACMH 
activities can be found on the OMH Web site under the heading About 
OMH.

DATES: The conference call will be held on December 5, 2017, 1:00 p.m.-
3:00 p.m. ET.

ADDRESSES: Instructions regarding participating in the call will be 
given at the time of preregistration.

[[Page 50653]]


FOR FURTHER INFORMATION CONTACT: Dr. Minh Wendt, Designated Federal 
Officer, Advisory Committee on Minority Health, Office of Minority 
Health, Department of Health and Human Services, Tower Building, 1101 
Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240-453-
8222; fax: 240-453-8223; email [email protected].

SUPPLEMENTARY INFORMATION: In accordance with Public Law 105-392, the 
ACMH was established to provide advice to the Deputy Assistant 
Secretary for Minority Health on improving the health of each racial 
and ethnic minority group and on the development of goals and specific 
program activities of the OMH.
    The topics to be discussed during the teleconference include 
finalizing recommendations regarding improving the access and quality 
of data related to the opioid usage and health disparities. The 
recommendations will be given to the Deputy Assistant Secretary for 
Minority Health.
    This call will be limited to 125 participants. The OMH will make 
every effort to accommodate persons with special needs. Individuals who 
have special needs for which special accommodations may be required 
should contact Professional and Scientific Associates at (703) 234-1700 
and reference this meeting. Requests for special accommodations should 
be made at least ten (10) business days prior to the meeting.
    Members of the public will have an opportunity to provide comments 
at the meeting. Public comments will be limited to two minutes per 
speaker during the time allotted. Individuals who would like to submit 
written statements should email, mail, or fax their comments to the 
designated contact at least seven (7) business days prior to the 
meeting.
    Any members of the public who wish to have electronic or printed 
material distributed to ACMH members should email [email protected] or 
mail their materials to the Designated Federal Officer, ACMH, Tower 
Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852, 
prior to close of business on November 28, 2017.

    Dated: October 27, 2017.
Minh Wendt,
Designated Federal Officer, Advisory Committee on Minority Health.
[FR Doc. 2017-23816 Filed 10-31-17; 8:45 am]
 BILLING CODE 4150-29-P